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Hexachlorobenzene Exposure
Widespread Toxicant Produces Pervasive Effects
Toxicogenomics work in a rat model system has given new insight
into how chemical toxicants can effect large-scale stress responses in
the immune system [EHP 112:782–791]. This month, Janine
Ezendam and colleagues at Utrecht University, the Netherlands
National Institute for Public Health and the Environment, and
Novartis Pharma in Basel, Switzerland, use gene expression analysis
to examine the impact of subchronic exposure to an important
environmental toxicant, hexachlorobenzene (HCB), on multiple
organ systems. They find that previously noted effects and newly
discovered ones come together in a dramatic inflammatory response
that touches multiple systems in exposed animals. 
Primarily an antifungal pesticide, HCB has been out of commer-
cial use in the United States since 1965 and is banned in many coun-
tries. Yet new HCB still enters the environment as a by-product of
several activities, including the manufacture of other chemicals, wood
preservation, and the burning of municipal garbage. It can build up in
wheat, grasses, and some vegetables. With a half-life in soil of up to
six years, the once widely used chemical is still found concentrated in
fish, marine mammals, birds, and lichens, as well as in grazing animals
that eat lichens or grass, and in animals that eat fish. It turns up in the
human food supply in contaminated dairy products,
meat, and fish. Low levels have been identified in the
fatty tissue of almost all people tested, according to the
Agency for Toxic Substances and Disease Registry. 
The accidental exposure of 3,000–5,000 people in
Turkey between 1955 and 1959 provided a deeper, albeit
tragic, understanding of HCB’s effects in exposed indi-
viduals and in children born following maternal expo-
sure. Humans and rats have been found to share many
responses to HCB exposure, including porphyria (a
buildup of porphyrins, the ring-shaped building blocks of
heme, that results in skin lesions), neurotoxic effects,
reproductive effects, and immune effects. Single small
doses are relatively nontoxic, but continued exposure,
even to small amounts, leads to breakdowns in health. 
Brown Norway rats are especially susceptible to the
immune effects of HCB. Ezendam and colleagues
exposed Brown Norway rats for four weeks to ingested
HCB at concentrations up to 450 milligrams per kilo-
gram. Using DNA microarray analysis, the team
demonstrated the impact of HCB on gene expression in
the spleen, mesenteric lymph node (MLN), thymus,
blood, liver, and kidney. Probing microarrays revealed
substantial changes in gene expression in the spleen,
blood, liver, kidney, and MLN. Overall, gene expres-
sion in the spleen, blood, and liver responded in a dose-
dependent way to changes in HCB exposure. Changes
in the kidney and MLN were less dose-dependent, and
the thymus, an organ not believed to be an HCB target,
showed few changes. 
Genes related to the inflammatory response were
among the strongest responders. Expression of genes
related to macrophages were noted in the spleen, MLN,
and liver. All of these organs house macrophages,
phagocyte immune cells that secrete chemokines and
cytokines, the signaling molecules that coordinate the
overall immune response. These changes were in line
with the known significance of macrophages in rats’
response to HCB. 
Several inflammation-promoting elements, including
interleukin-6 (a cytokine that works across the immune
system, promoting B cell and macrophage differentiation as well as T
cell growth) were induced in different tissues by the exposure.
Members of the mitogen-activated protein kinase family of signal
transduction molecules were induced in the kidney, and a transcrip-
tion factor known as signal transducer and activator of transcription 1
was induced in the liver. This suggests that the response to HCB
exposure includes both up- and downregulation of cytokine signaling.
Further expression in the liver and kidney, as well as in the spleen and
MLN, included genes related to oxidative stress and antioxidants, to
components of the complement pathway, to chemokines and their
receptors, and to cell adhesion molecules. 
Taken together, the data provide a big-picture view with consider-
able detail: the pattern of gene expression indicates that exposure to
HCB triggers an inflammatory response that touches all of the organ
systems studied except the thymus, as well as other effects not related
to the immune system. The gene expression profiles confirm known
elements of the pathology induced by HCB and extend them with
insights about the involvement of other factors, including cytokines,
chemokines, antioxidants, and other factors. A complete list of signifi-
cant changes in gene expression, including many genes not discussed
directly in the paper, can be found at ArrayExpress, the European
Bioinformatics Institute’s public repository for array data, at
http://www.ebi.ac.uk/arrayexpress/. –Victoria McGovern
Multiple wounds. The toxicant hexachlorobenzene inflicts multisystemic damage
through initiation of an inflammatory response.